RBM Partnership to End Malaria social media kit
This year’s #WorldMalariaDay theme is #TimeToDeliverZeroMalaria. The fight against malaria needs critical attention. If we #invest in malaria control, #innovate new tools, and #implement sustainable approaches, together we can #EndMalaria. Share the message far and wide by downloading and sharing content from the social media kit.
Devex: Climate change requires adapting malaria prevention campaigns
Preventing disease with seasonally distributed medicines saves lives. In 2022 alone, the intervention protected over 48 million children in 17 countries. But what happens when climate change causes shifts in the malaria season, and therefore the timing and duration of these preventive campaigns? Read the full MMV-authored article on Devex.
Project Syndicate: Monoclonal Antibodies — A New Weapon Against Malaria
Over the past three years, the COVID-19 pandemic has dominated news headlines and spurred scientific innovation. Innovation in tools to combat malaria should take a page from the pandemic playbook: one benefit of the flood of COVID-19 research is that it demonstrated the enormous potential of monoclonal antibodies. These drugs are artificially synthesized laboratory-made copies of the proteins that a person’s immune system produces to destroy specific foreign invaders. Read the full article on Project Syndicate.
The Telegraph: Photographer Rankin swaps celebrities for scientists
Acclaimed artist – renowned for his portraits of Kate Moss, Madonna, David Bowie and Queen Elizabeth II – fixes his lens on hidden heroes in science, the "new rock n roll stars of our time." Eirini Tseligka, pharmacology scientist at MMV, is featured in the article posted in The Telegraph.
MMV echoes Swiss Malaria Group's call to invest and innovate to end to malaria
On World Malaria Day, the Swiss Malaria Group, of which MMV is a part, calls for more commitment from funders and the international community to combat malaria. Switzerland is a pioneer in innovation: for decades, actors in Switzerland have contributed fundamentally to the development and distribution of drugs, vaccines, diagnostics, bed nets and insecticides. Despite these successes, there is now an annual funding gap of around US$ 3.8 billion. Read the news story and press release.
MMV's advertorial published in The Guardian and Media Planet
MMV joined the malaria community in participating in the Media Planet World Malaria Day campaign. We contributed ads published both digitally on the Global Cause website and in print in The Guardian newspaper supplement.
Voice of Islam radio interview
Voice of Islam discusses malaria and options for prevention, including both vaccines and medicines, with a guest panel. MMV's André-Marie Tchouatieu, Director of Access & Product Management discusses seasonal malaria chemoprevention for children. Visit the podcast webpage to listen.
WHO stories, messages and social media assets
This World Malaria Day is marked under the theme “Time to deliver zero malaria: invest, innovate, implement." Within this theme, WHO focuses on the third “i” – implement – and notably the critical importance of reaching marginalized populations with the tools and strategies that are available today. Visit the dedicated webpage for stories, key messages and social media assets from WHO.
Asia Pacific Malaria Elimination Network video
The Asia Pacific Malaria Elimination Network Vivax Working Group video outlines how the group is accelerating progress towards the elimination of Plasmodium vivax malaria, sharing insights and perspectives from National Malaria Programme Managers, experts and stakeholders who are directly involved in the group's work.
Annual Malaria in Pregnancy Working Group meeting video
This video showcases the 2022 RBM Malaria in Pregnancy Working Group (MiPWG) Meeting in Accra, Ghana. The MiPWG is a diverse group of stakeholders that convenes annually to share updates on progress to defeat malaria in pregnancy.
Partnership for Vivax Elimination (PAVE) Peru vlog
Here is a video blog from the MMV Peru team following the launch of the PAVE Peru feasibility study in March 2023. The study will examine the feasibility, acceptability, and cost implications of providing primaquine or tafenoquine after G6PD testing in real-world settings.
Peru Ministry of Health World Malaria Day event
Elisa Vidal, MMV's Regional Advisor for Latin America, will be presenting at the Ministry of Health Peru (MINSA) World Malaria Day event on current feasibility studies and new tools to combat Plasmodium vivax malaria. The event will be broadcast in Spanish at the following link: https://minsa-gob-pe.zoom.us/j/98834620273#success.
Brazil Ministry of Health World Malaria Day event
The Brazilian Ministry of Health (MoH) is hosting an event on World Malaria Day to reaffirm the government's commitment to eliminating malaria. The event will include a presentation led by the TRuST Principal Investigator, Marcus Lacerda (FMT) on the key findings of the TRuST study - the first, and biggest real-world study on tafenoquine and G6PD testing.